GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Medesis Pharma SA (XPAR:ALMDP) » Definitions » Price-to-Operating-Cash-Flow

Medesis Pharma (XPAR:ALMDP) Price-to-Operating-Cash-Flow : (As of Jun. 03, 2025)


View and export this data going back to 2021. Start your Free Trial

What is Medesis Pharma Price-to-Operating-Cash-Flow?

As of today (2025-06-03), Medesis Pharma's share price is €0.35. Medesis Pharma's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Jun. 2024 was €0.00. Hence, Medesis Pharma's Price-to-Operating-Cash-Flow Ratio for today is .

The historical rank and industry rank for Medesis Pharma's Price-to-Operating-Cash-Flow or its related term are showing as below:

XPAR:ALMDP's Price-to-Operating-Cash-Flow is not ranked *
in the Biotechnology industry.
Industry Median: 24.275
* Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.

Medesis Pharma's Cash Flow from Operations per share for the six months ended in Jun. 2024 was €0.00. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Jun. 2024 was €0.00.


Medesis Pharma Price-to-Operating-Cash-Flow Historical Data

The historical data trend for Medesis Pharma's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medesis Pharma Price-to-Operating-Cash-Flow Chart

Medesis Pharma Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Operating-Cash-Flow
Get a 7-Day Free Trial - - - - -

Medesis Pharma Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Price-to-Operating-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Medesis Pharma's Price-to-Operating-Cash-Flow

For the Biotechnology subindustry, Medesis Pharma's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medesis Pharma's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Medesis Pharma's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Medesis Pharma's Price-to-Operating-Cash-Flow falls into.


;
;

Medesis Pharma Price-to-Operating-Cash-Flow Calculation

Medesis Pharma's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio=Share Price/Cash Flow from Operations per share (TTM)
=0.35/0
=

Medesis Pharma's Share Price of today is €0.35.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Medesis Pharma's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Jun. 2024 was €0.00.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio=Market Cap/Cash Flow from Operations

Medesis Pharma Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Medesis Pharma's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Medesis Pharma Business Description

Traded in Other Exchanges
N/A
Address
Loree des Mas, Avenue du golf, Baillargues, Montpellier, FRA, 34670
Medesis Pharma SA is a clinical development stage biopharmaceutical company. It is engaged in the development of orally administered molecule drug candidates to expand therapeutic usefulness to address major unmet medical needs.

Medesis Pharma Headlines

No Headlines